ESR2 and neoplasm: However, H19 silencing decreased ER-beta expression and reduced tumor progression in PTC stem cells indicating the fact that ER-beta and H19 down regulation via E2 could be used as a therapeutic approach to reduce tumor progression in PTC (Chu et al., 2014).